glp 1 from hers Hims & releases competitively-priced GLP-1 GLP-1 Compounding Crackdown | Double-Helix

A recent study suggests that a GLP-1 drug, liraglutide, may protect the brains of people with mild Alzheimers disease, slowing cognitive decline by 18% over one year.

In clinical trials, people using GLP-1 drugs lost an average of about 10 pounds more than people using a placebo

Ph 2 datathat showed weight loss of between 9.4% and 14.7% after 36 weeks on the drug compared to 2.3% for the placebo group and is currently in Ph 3

Methods Adults (18 years old) with T2D required at least one prescription for injectable semaglutide at index date (treatment switch), at least one prescription for any other GLP-1 RA in the previous 365 days, a baseline HbA1c and/or weight measurement in the 90 days pre-index and a follow-up measurement at 180 and 365 days post-index